American Bio Medica Corporation
ABMC
$0.0001
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 596.31% | 2.46% | -147.36% | -63.27% | 31.83% |
| Total Depreciation and Amortization | -38.46% | -13.33% | -29.41% | -27.78% | -27.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15,200.00% | -103.55% | 99.52% | -185.71% | -88.71% |
| Change in Net Operating Assets | -140.71% | -134.43% | 466.67% | 758.82% | 516.36% |
| Cash from Operations | -2,692.31% | -481.88% | 65.44% | 73.15% | 96.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -45.89% | 38.04% | -43.80% | -50.62% | -52.66% |
| Total Debt Repaid | 81.72% | 94.07% | 32.76% | 39.45% | 16.10% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 276.47% | 838.37% | -63.60% | -75.89% | -126.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 134.69% | -67.57% | -27.27% | 54.55% | -180.00% |